Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

5 big analyst AI moves: Two major 2023 beneficiaries downgraded

Published 01/07/2024, 08:10 AM
Updated 01/07/2024, 08:10 AM
© Reuters

Here are the biggest analyst moves in the area of artificial intelligence (AI) for this week.

InvestingPro subscribers always get first dibs on market-moving AI analsyt comments.

Goldman sees more outperformance from AI beneficiaries

Goldman Sachs analysts are out with their 2024 outlook for IT Hardware and networking equipment providers. In essence, they argue that AI beneficiaries should continue to outperform in 2024.

Top Picks in this regard include Arista Networks (NYSE:ANET), which is expected to continue benefiting from accelerating capex growth at its key hyperscale customers (Microsoft and Meta) and milestones that support Ethernet as an AI networking fabric.

Moreover, Dell Technologies Inc (NYSE:DELL) is also flagged as a company that should see growing demand for AI servers as “infrastructure investments expand beyond hyperscalers (first movers) to AI cloud service providers and eventually enterprise.”

InvestingPro

Mixed comments on Nvidia

Bank of America analysts maintained NVIDIA Corporation (NASDAQ:NVDA) as a Top Pick in the chip sector and highlighted that the company’s “genAI dominance can potentially help generate ~ $100bn of incremental free cash flow over the next two years (CY24/CY25E).”

“In our view NVDA’s solid FCF generation creates optionality in addressing these concerns, and in helping to expand its trading multiple back to its historical median 35x-40x,” the analysts said.

On the other hand, DA Davidson analysts initiated research coverage on NVDA stock with a Neutral rating and a $410 per share price target.

“While we continue to believe that generative AI is the most important transformative technology since the Internet, we do not expect the same level of investment we saw in 2023 continuing beyond 2024,” analysts said in a note.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Morgan Stanley discusses AI regulation

Analysts at Morgan Stanley shared key takeaways following their conversation with experts from Stanford University on AI regulation.

“We continue to believe that the development and implementation of AI regulation in the US will not be imminent and discuss multiple hurdles to clear,” analysts wrote.

Overall, analysts argue that development and implementation of AI regulation in the United States is still in the early innings and that it will “take years to implement anything enforceable in the United States.”

“The experts cited resource constraints at the Federal agency level and asymmetrical information between government and industry as two key factors that could hinder successful AI regulation.”

2023 AI beneficiaries cut

Two major AI beneficiaries from 2023, MongoDB (NASDAQ:MDB) and Palantir Technologies Inc (NYSE:PLTR), saw their ratings cut this week. The former was downgraded at UBS after a 108% rally in 2023.

“We still like the durable ~30% long-term growth story, but absent a material database revs pull-through from AI workloads in 2024, we conclude that a continued re-rating of the stock is unlikely,” UBS analysts said on MDB.

Elsewhere, Palantir is 'overhyped on AI' and therefore Jefferies analysts downgraded it to Neutral.

“We are concerned that the stock has rallied to unsustainable valuation levels primarily on the back of AI euphoria (and retail trading momentum) with no monetization strategy,” the analyst said in a note.

“We are still fundamental fans and believe that the company has potential to gain share in an underpenetrated and large TAM but believe that there is more risk than reward at current levels, even when factoring in upward estimate revisions.”

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

UiPath gets a new bull

William Blair analysts initiated research coverage on pure AI name UiPath (NYSE: NYSE:PATH) with an Outperform rating.

“We believe that UiPath is a leader in the workflow automation and process optimization markets. The company’s platform helps automate manual workflows through user interface (UI) and application programming interface (API)-based automations,” analysts wrote.

“UiPath addresses complex and enterprise-grade processes, which has led to the company’s platform becoming mission critical for its customers (as evidenced by its strong gross retention rate of 97%).”

All in all, analysts see PATH delivering “durable growth and expanding margins over the next few years.”

InvestingPro

Latest comments

eatch nvda hit 540 this week
I wokld live yo review their predictions 12 months ago!! The border is secure and crime is down as well! Clueless
US Bankruptcies jump 18% in 2023. I guess this was 'priced in' as stocks soared 5K in Nov.. lol
Typical mealy mouth analyst at Jeffries shouting down PLTR. Yet they are still fans, like the huge TAM PLTR plays in and the upward revisions don’t justify the risk??? How many times does PLTR have to beat expectations and increase profits for these analysts to understand PLTR is a leader and a great stock?
And yet money losing Goldman Sachs can't predict their own performance ......
I love the analyst calls and the knowledge and wisdom and investment.com brings to me now I'm ready to make my next move
Android chrome
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.